EP Patent

EP1357928A2 — A novel pharmaceutical compound and methods of making and using same

Assigned to Shire LLC · Expires 2003-11-05 · 23y expired

What this patent protects

A pharmaceutical composition comprising : a polypeptide; and an active agent attached to said polypeptide.

USPTO Abstract

A pharmaceutical composition comprising : a polypeptide; and an active agent attached to said polypeptide.

Drugs covered by this patent

Patent Metadata

Patent number
EP1357928A2
Jurisdiction
EP
Classification
Expires
2003-11-05
Drug substance claim
No
Drug product claim
No
Assignee
Shire LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.